These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15684176)

  • 1. Trospium chloride (Sanctura): another anticholinergic for overactive bladder.
    Obstet Gynecol; 2005 Feb; 105(2):431-2. PubMed ID: 15684176
    [No Abstract]   [Full Text] [Related]  

  • 2. Trospium chloride: an anticholinergic quaternary ammonium compound for the treatment of overactive bladder.
    Zinner NR
    Expert Opin Pharmacother; 2005 Jul; 6(8):1409-20. PubMed ID: 16013990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trospium chloride (Sanctura): another anticholinergic for overactive bladder.
    Med Lett Drugs Ther; 2004 Aug; 46(1188):63-4. PubMed ID: 15289745
    [No Abstract]   [Full Text] [Related]  

  • 4. Trospium chloride for the treatment of overactive bladder with urge incontinence.
    Singh-Franco D; Machado C; Tuteja S; Zapantis A
    Clin Ther; 2005 May; 27(5):511-30. PubMed ID: 15978301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [High doses of trospium chloride in patients with idiopathic overactive bladder. Data of large-scale, multicenter observational program Resource].
    Krivoborodov GG; Tur EI; Efremov NS; Shkolnikov ME
    Urologiia; 2016 Aug; (4):29-34. PubMed ID: 28247723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of anticholinergic use for the treatment of overactive bladder on cognitive function in postmenopausal women.
    Geller EJ; Crane AK; Wells EC; Robinson BL; Jannelli ML; Khandelwal CM; Connolly A; Parnell BA; Matthews CA; Dumond JB; Busby-Whitehead J
    Clin Drug Investig; 2012 Oct; 32(10):697-705. PubMed ID: 22873491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trospium chloride in patients with neurogenic detrusor overactivity: is dose titration of benefit to the patients?
    Menarini M; Del Popolo G; Di Benedetto P; Haselmann J; Bödeker RH; Schwantes U; Madersbacher H;
    Int J Clin Pharmacol Ther; 2006 Dec; 44(12):623-32. PubMed ID: 17190372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trospium chloride in the management of overactive bladder.
    Rovner ES
    Drugs; 2004; 64(21):2433-46. PubMed ID: 15482001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trospium chloride (Sanctura)--new to the U.S. for overactive bladder.
    Gaines KK
    Urol Nurs; 2005 Feb; 25(1):64-5, 52. PubMed ID: 15779697
    [No Abstract]   [Full Text] [Related]  

  • 10. Trospium chloride: Distinct among other anticholinergic agents available for the treatment of overactive bladder.
    Staskin DR
    Urol Clin North Am; 2006 Nov; 33(4):465-73, viii. PubMed ID: 17011382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy and tolerability of solifenacin succinate with or without previous use of trospium chloride.
    Metello J; Nogueira B; Torgal M; Colaço J; Vieira A; Gonçalves V; Retto H
    Int Urogynecol J Pelvic Floor Dysfunct; 2007 Sep; 18(9):1021-5. PubMed ID: 17211528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trospium chloride improves overactive bladder symptoms: a multicenter phase III trial.
    Zinner N; Gittelman M; Harris R; Susset J; Kanelos A; Auerbach S;
    J Urol; 2004 Jun; 171(6 Pt 1):2311-5, quiz 2435. PubMed ID: 15126811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trospium chloride: an effective option for medical treatment of bladder overactivity.
    Füsgen I; Hauri D
    Int J Clin Pharmacol Ther; 2000 May; 38(5):223-34. PubMed ID: 10839466
    [No Abstract]   [Full Text] [Related]  

  • 14. Limitations of anticholinergic cycling in patients with overactive bladder (OAB) with urinary incontinence (UI): results from the CONsequences of Treatment Refractory Overactive bLadder (CONTROL) study.
    Chancellor MB; Yehoshua A; Waweru C; Globe D; Cheng IN; Campbell KL; Joshi M; Pulicharam R
    Int Urol Nephrol; 2016 Jul; 48(7):1029-36. PubMed ID: 27032397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the population pharmacokinetic characteristics of once-daily trospium chloride 60 mg extended-release capsules in patients with overactive bladder and in healthy subjects.
    Harnett MD; Shipley J; MacLean L; Schwiderski U; Sandage BW
    Clin Drug Investig; 2013 Feb; 33(2):133-41. PubMed ID: 23203138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of trospium chloride on somnolence and sleepiness in patients with overactive bladder.
    Staskin DR; Harnett MD
    Curr Urol Rep; 2004 Dec; 5(6):423-6. PubMed ID: 15541209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia.
    Brannan SK; Sawchak S; Miller AC; Lieberman JA; Paul SM; Breier A
    N Engl J Med; 2021 Feb; 384(8):717-726. PubMed ID: 33626254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of trospium chloride.
    Doroshyenko O; Jetter A; Odenthal KP; Fuhr U
    Clin Pharmacokinet; 2005; 44(7):701-20. PubMed ID: 15966754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity is associated with a more severe overactive bladder disease state that is effectively treated with once-daily administration of trospium chloride extended release.
    Chancellor MB; Oefelein MG; Vasavada S
    Neurourol Urodyn; 2010 Apr; 29(4):551-4. PubMed ID: 19634167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial comment on: Treatment with propiverine in children suffering from nonneurogenic overactive bladder and urinary incontinence: results of a randomized placebo-controlled phase 3 clinical trial.
    Lazzeri M
    Eur Urol; 2009 Mar; 55(3):737-8. PubMed ID: 18502027
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.